Fuel new breakthroughs in oncology with spatial omics
Building the largest spatial omics dataset in oncology
Apply AI to large-scale spatial omics to discover:
New therapeutic targets
New patient subgroups
New diagnostic and prognostic spatial biomarkers
New treatment response and resistance mechanisms
Pioneering large-scale spatial biology with world-leading academic and industry partners
7
Cancer indications
NSCLC, Ovarian, Bladder, Mesothelioma, Glioblastoma, Breast Cancer, DLBCL
6
Data modalities
Spatial transcriptomics, Single-cell RNA-seq, Bulk RNA-seq, Clinical data, WES, H&E
5
Academic partners
Gustave Roussy, University of Pittsburgh, Uniklinikum Erlangen, Charitè, CHUV
MOSAIC + Owkin
Follow our spatial biology journey
Owkin's MOSAIC dataset will allow us to decode the tumour microenvironment. We combine spatial omics with AI to decode complex biology and ensure every patient gets the right treatment.
Why work with Owkin to leverage spatial omics data?